MK0476, montelukast sodium
Sponsors
Organon and Co
Conditions
Asthma, BronchialRhinitis, Allergic, PerennialRhinitis, Allergic, Seasonal
Phase 3
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
CompletedNCT00092105
Start: 2002-04-01End: 2003-01-28Updated: 2024-08-14
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
CompletedNCT00092885
Start: 2003-03-31End: 2003-10-31Updated: 2024-08-15